Navigation Links
Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Boehringer Ingelheim’s Application to Expand Approved Uses for Pradaxa
Date:8/29/2013

New York, New York (PRWEB) August 29, 2013

As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) involving allegations that the drug caused serious, life-threatening episodes of internal bleeding continue to move forward, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has accepted a marketing application to expand the approved uses for the blood thinner. According to a report from Bloomberg Businessweek, Boehringer Ingelheim is seeking to have Pradaxa approved as a treatment for two potentially fatal types of blood clots, deep vein thrombosis and pulmonary embolism.*

“Hundreds of Pradaxa lawsuits have already been filed by plaintiffs who claim to have suffered frightening episodes of internal bleeding while taking this blood thinner, and our Firm continues to regularly receive inquiries from alleged victims of Pradaxa side effects. Unlike some alternative blood thinner treatments, there is no readily available antidote for bleeding that may occur with Pradaxa,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding.

Pradaxa Lawsuits
According to court documents, more than 1,440 Pradaxa lawsuits have been filed in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, on behalf of alleged victims of Pradaxa bleeding. All of these claims accuse Boehringer Ingelheim of failing to provide adequate warnings regarding Pradaxa side effects, particularly the lack of an antidote for internal bleeding. The first trials in the Pradaxa bleeding litigation are scheduled to begin in the fall of 2014. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

Pradaxa received FDA approval in October 2010 as a treatment for patients with atrial fibrillation. However, according to a Bloomberg.com report published this past December, regulators in the U.S. and overseas have issued a number of Pradaxa alerts regarding its association with serious internal bleeding, especially the present lack of an antidote for this occurrence. While Pradaxa was touted as an improvement over warfarin, the hemorrhaging that sometimes occurs with this decades- old blood thinner can be staunched with the administration of vitamin K.** In January , a study published by the Institute for Safe Medicine Practices reported that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.

Alleged victims of Pradaxa may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Read More about Pradaxa bleeding at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation, please call 800-511-5092.

*businessweek.com/ap/2013-08-28/boehringer-ingelheim-seeks-new-approval-of-pradaxa
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb11076315.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
2. Pradaxa Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Finding that Pradaxa Users Face Significantly Higher Risk of Bleeding Side-Effects
3. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
4. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Scheduling of Next Case Management Conference in Federal Pradaxa Bleeding Litigation
5. Doyle Raizner Pradaxa Case Chosen for Bellwether Early Trial Consideration
6. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
7. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
8. Pradaxa Lawsuit Attorneys at Wright & Schulte LLC Report on Scheduling of Bellwether Trials in Federal Pradaxa Bleeding Lawsuits
9. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes New Study Linking Pradaxa to Increased Heart Attack Risk
10. New Lawsuit on Pradaxa Bleeding: Now, AttorneyOne Can Provide Advice
11. New Study Casts Doubt on FDA Pradaxa Conclusions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... 2017 , ... The Semper Fi Fund, one of the nation’s highest-rated veteran ... of videos and a compelling documentary that provide unique insights and powerful advice to ... of its ongoing mission. , Each of the videos focuses on a specific issue ...
(Date:9/19/2017)... Delaware (PRWEB) , ... September 19, 2017 , ... Driving ... and Safety Training Company by Training Industry Inc. as part of its mission to ... , Selection to the first annual 2017 Top 20 Health and Safety Training ...
(Date:9/19/2017)... ... September 19, 2017 , ... The ISO 9001 standard sets out the ... become more efficient and improve customer satisfaction. ISO 9001:2015 was released in 2015 and ... a deadline of September 2018. , As described in this white ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... Colleyville, TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® ... it’s the first in the U.S. to incorporate magnesium, a critical property for ...
(Date:9/19/2017)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... Director of its Pflugerville- FM 685 facility. , “We are pleased to announce ... location,” said Dr. Stephen Van Roekel, Reginal Medical Officer of First Choice Emergency Room ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)...  Getinge, a leading global provider of innovative ... program -- "Color for the Kids!" -- to ... by The Children,s Heart Foundation. Pediatric patients and ... encouraged to download a coloring picture at ... the gallery on the website. For each artwork ...
(Date:9/1/2017)... PALMER, Mass. , Sept. 1, 2017 ... Complete HealthCare Solutions, Inc , highlights opportunities for growth ... Street Journal report that Marlin Equity is seeking a ... is an annual award-winning 22-year-old healthcare solutions Value Added ... market.  "As the ...
(Date:8/31/2017)... , Aug. 31, 2017 PM360,s annual ... guide to the latest innovations happening across the industry. ... publication to focus on providing a comprehensive look at ... issue covers the most innovative companies, startups, divisions, products, ... "Everyone in this industry wants ...
Breaking Medicine Technology: